TRAD CHI MED (00570.HK) announced its performance for the fiscal year 2025, with a revenue of RMB 14.745 billion, a year-on-year decrease of 10.7%. It recorded a loss of RMB 342 million, compared to a net profit of RMB 54.07 million in the previous year, turning from profit to loss; the loss per share is 6.79 cents. No final dividend will be distributed